Ireland· IE-PA-PA0749/054/001
Zanaflex 2 mg Tablets
A tizanidine product containing tizanidine, registered in Ireland by Teva Pharma B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Tizanidine is registered in 14 of 19 countries.
Countries holding a registration under ATC M03BX02 (tizanidine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Tizanidine · ATC M03BX02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tizanidine costs, country by country.
Normalised to the WHO defined daily dose (12 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tizanidine · price per daily dose (12 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.38
The record
At a glance
HPRA (Ireland)- Active substance
- Tizanidine
- Manufacturer
- Teva Pharma B.V.
- Country
- Ireland (IE)
- ATC code
- M03BX02
- ATC class
- Tizanidine
- Defined daily dose
- 12 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0749/054/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
384 interactions on record for tizanidine.
Graded by severity as the source publishes them — 78 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tizanidine · interactions on record
384 records
- 78 severe
- 177 moderate
- 2 minor
- 87 info
Most severe, free to view
- CimetidineA02BA01severe
- FamotidineA02BA03severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
40 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tizanidine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTIZANDINEDirect_Rx
- United KingdomTizagelan 2mg tabletsG.L. Pharma UK Ltd
- FinlandSirdaludOrifarm Oy
- NetherlandsChordyna 2 mg, tablettenBausch Health Ireland Limited
- SwitzerlandSirdalud 2 mg, TablettenSandoz Pharmaceuticals AG
- CzechiaSIRDALUDNovartis s.r.o., Praha
- PolandChordynaBausch Health Ireland Ltd.
- NorwaySirdaludBexal
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Sirdalud, Sirdalud Mr
- Belgium · Sirdalud
- Bulgaria · Tizanidine Teva, Тизанидин Tева
- Czechia · Sirdalud
- Germany · Sirdalud, Tizanidin Ascend
- Denmark · Sirdalud Retard, Tizanidin Teva
- Estonia · Sirdalud
- Spain · Sirdalud
- Finland · Sirdalud, Sirdalud Retard
- United Kingdom (Northern Ireland) · Tizagelan, Tizanidine
- Greece · Sirdalud
- Croatia · Tizanidin Altamedics
- Hungary · Sirdalud, Sirdalud Mr
- Italy · Navizan, Sirdalud
- Lithuania · Sirdalud
- Luxembourg · Sirdalud
- Latvia · Sirdalud
- Netherlands · Chordyna, Sirdalud
- Poland · Chordyna, Sirdalud Mr
- Portugal · Sirdalud, Tizanidina Teva
- Slovenia · Sirdalud
- Slovakia · Sirdalud
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3dad071-08c2-4424-aee6-acd4f77499b3 GET /v1/drugs/b3dad071-08c2-4424-aee6-acd4f77499b3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"M03BX",
"M03BX02"
],
"strength": null,
"pa_number": "PA0749/054/001",
"substances": [
"Tizanidine"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "25/01/2008",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about tizanidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.